Lack of the detection of XMRV or polytropic MLV-related sequences in blood cells from HIV-1-infected patients in spain

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 2, 2012, Pages 101-104

  Luczkowiak, Joanna ^a   Martínez Prats, Lorena ^a   Sierra, Olalla ^a   Fiorante, Silvana ^a   Rubio, Rafael ^a   Pulido, Federico ^a   Otero, Joaquin R ^a   Delgado, Rafael ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Blood borne agents; Chronic fatigue syndrome; Hepatitis C virus; HIV 1; XMRV

Indexed keywords

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAVENOUS DRUG ABUSE; MALE; MIXED INFECTION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPAIN; XENOTROPIC MULV RELATED VIRUS;

ANIMALS; DNA, VIRAL; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; SPAIN; TUMOR VIRUS INFECTIONS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84857030139     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318238b596     Document Type: Article

References (24)

1. Urisman A, Molinaro RJ, Fisher N, et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006; 2: 211-225.
2. Schlaberg R, Choe DJ, Brown KR, et al. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A. 2009; 106: 16351-16356.
3. Weiss RA. A cautionary tale of virus and disease. BMC Biology. 2010; 8: 124.
4. Lombardi VC, Ruscetti FW, Das Gupta J, et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science. 2009; 326: 585-531.
5. Erlwein O, Kaye S, McClure MO, et al. Failure to detect the novel retrovirus XMRV in Chronic Fatigue Syndrome. PLoS One. 2010; 5: e8519.
6. Groom HC, Yap MW, Galao RP, et al. Absence of xenotropic murine leukemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology. 2010; 7: 10.
7. van Kuppeveld FJ, de Jong AS, Lanke KH, et al. Prevalence of xenotropic murine leukemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ. 2010; 340: C1018.
8. Switzer WM, Jia H, Hohn O, et al. Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology. 2010; 7: 57.
9. Lo SC, Pripuzova N, Li B, et al. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci USA. 2010; 107: 15874-15879.
10. Association Bulletin #10-03-Chronic Fatigue Syndrome and Blood Donation. AABB: advancing transfusion and cellular therapies worldwide. Available at: www.aabb.org/. Accessed June 2010.
11. Barnes E, Flanagan P, Brown A, et al. Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections. J Infect Dis. 2010; 202: 1482-1485.
12. Danielson BP, Ayala GE, Kimata JT. Detection of xenotropic murine leukemia virus-related virus in normal land tumor tissue of patients from the southern United States with prostate cancer is dependent of specific polymerase chain reaction conditions. J Infect Dis. 2010; 202: 1470-1477.
13. Henrich TJ, Li JZ, Felsenstein D, et al. Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis. 2010; 202: 1478-1481.
14. Luczkowiak J, Sierra O, Gonzalez-Martin JJ, et al. No xenotropic murine leukemia virus-related virus detected in fibromyalgia patients. Emerg Infect Dis. 2011; 17: 312-313.
15. Singh IR, Gorzynski JE, Drobysheva D, et al. Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. PLoS One. 2010; 5: e99948.
16. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997; 278: 1295-1300. (Pubitemid 27495742)
17. Kearney M, Maldarelli F. Current status of xenotropic murine leukemia virus-related retrovirus in chronic fatigue syndrome and prostate cancer: reach for a scorecard, not a prescription pad. J Infect Dis. 2010; 202: 1463-1466.
18. Paprotka T, Delviks-Frankenberry KA, Cingöz O, et al. Recombinant origin of the retrovirus XMRV. Science. 2011; 333: 97-101.
19. Aloia AL, Sfanos KS, Isaacs WB, et al. XMRV: a new virus in prostate cancer?. Cancer Res. 2010; 70: 10028-10033.
20. Hue S, Gray ER, Gall A, et al. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology. 2010; 7: 111.
21. Kaiser J. No meeting of minds on XMRV's role in chronic fatigue. Science. 2010; 329: 1454.
22. Sato E, Furuta RA, Miyazawa T. An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR Kit is amplified using standard primers for XMRV. Retrovirology. 2010; 7: 110.
23. Oakes B, Tai AK, Cingöz O, et al. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology. 2010; 7: 109.
24. Smith RA. Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology. 2010; 7: 112.